Abstract: In recent years, Chinese cardiovascular pharmacologists have made systematically in-depth study on cardiovascular diseases such as coronary heart disease, myocardial infarction, ischemia reperfusion injury, and atherosclerosis, investigating their pathogeneses and targets for intervention, as well as therapeutic drugs and the pharmacological mechanisms of action. By retrieving papers published in high-level academic journals during 2016-2017 by Chinese scholars, this paper reviewed research progress made by Chinese scholar in the field of cardiovascular pharmacology, providing reference for further research of relevant drugs.